<DOC>
	<DOCNO>NCT00471744</DOCNO>
	<brief_summary>The investigator hypothesize Levetiracetam effective Sulthiame treatment child BECTS . Patients enter HEAD-Studie either treat Leveitracetam Sulthiame 6 month period . Patients equally randomise one two treatment regimen . Administration medication blind capsule .</brief_summary>
	<brief_title>HEAD-Study Optimizing Treatment Children With BECTS</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsy , Rolandic</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Sulthiame</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1 . Age 6 12 year 2 . Weight 15 kg 60 kg 3 . At least two precede seizure within last six month study start 4 . Typical electroencephalogram ( EEG ) Rolando focus ( centrotemporal spike sharpwavefocus ) 5 . Diagnosis BECTS 6 . Written inform consent parent child 1 . Other form epilepsy ( e.g . continuous spike wave slow sleep [ CSWS ] , LandauKleffnersyndrome ) 2 . Preceding treatment antiepileptic drug 3 . Mental Retardation ( intelligence quotient [ IQ ] &lt; 85 ) 4 . Focal neurological deficit 5 . Relevant major internistic disease ( e.g . hepatopathy , nephropathy , endocrinopathy ) 6 . Participation another clinical trial within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>benign epilepsy</keyword>
	<keyword>pediatrics</keyword>
	<keyword>child</keyword>
	<keyword>rolandic epilepsy</keyword>
	<keyword>levetiracetam</keyword>
	<keyword>sulthiame</keyword>
</DOC>